Previously, we isolated two mutants of Bacteroides thetaiotaomicron that were unable to grow on the mucopolysaccharide chondroitin sulfate (CS). One of these mutants (46-1) was outcompeted by the wild type in the intestinal tracts of germfree mice, whereas the other mutant (46-4) competed equally with the wild type. In the present article, we report a detailed characterization of these two mutants. Assays of enzymes in the CS utilization pathway revealed that 46-1 did not express one of these enzymes, chondro-6-sulfatase. The absence of chondro-6-sulfatase activity in extracts from 46-1 allowed us to detect a previously unknown activity of another enzyme in the CS breakdown pathway, 13-glucuronidase. In addition to hydrolyzing its normal substrate (an unsulfated disaccharide), 1-glucuronidase also hydrolyzed the 6-sulfated disaccharide subunit of CS. Two-dimensional gel analysis of polypeptides produced by 46-1 showed that several proteins other than the 6-sulfatase were either missing or expressed aberrantly. Thus, 46-1 could be a regulatory mutant. Mutant 46-4 was unable to grow on CS, hyaluronic acid, or disaccharides of CS. Thus, expression of the CS pathway enzymes could not be induced. Nonetheless, the growth pattern of 46-4 and some other findings indicate that the structural genes for these enzymes were still intact. The most likely target of mutant 46-4 is a regulatory locus that is required for expression of CS utilization genes. A surprising characteristic of 46-1 was its inability to grow on heparin, a mucopolysaccharide which is structurally similar to CS but is utilized by a different pathway. This effect of 46-1 indicates that there is some link between the CS and heparin utilization pathways, two pathways that had previously appeared to be completely independent of each other. Mutant 46-4, unlike 46-1, grew normally on heparin. Thus, the inability of 46-1 to utilize heparin might have contributed to its inability to compete with the wild type in the germfree mouse intestine.
Some Bacteroides species, such as Bacteroides thetaiotaomicron, can ferment both host mucopolysaccharides and plant polysaccharides (20) . This raised the question of whether mucopolysaccharides could be a significant source of carbohydrate in the colon. To assess the importance of mucopolysaccharides as a carbon source for B. thetaiotaomicron in the intestine, Salyers et al. (19) isolated two transposon-generated mutants of B. thetaiotaomicron that could not grow on the mucopolysaccharide CS. These mutants were tested for the ability to compete with wild-type B. thetaiotaomicron for colonization of the intestinal tracts of germfree mice. One of the mutants, 46-1, was outcompeted by the wild type, whereas the other mutant, 46-4, was not (19) . Since both mutants were deficient in the ability to grow on CS, the difference in competitiveness could not be ascribed simply to the inability to use CS. In fact, 46-4 appeared to be more deficient than 46-1 in its ability to utilize mucopolysaccharides because 46-4 was also unable to grow on hyaluronic acid, a mucopolysaccharide that is structurally similar to CS except that it has no sulfate groups. By contrast, 46-1 could still grow on hyaluronic acid. The difference in ability to compete with the wild type in vivo was not due to some generalized growth defect in 46-1 because 46-1, like 46-4, grew as well as the wild type on polysaccharides that were structurally unrelated to CS and on monosaccharides, including the monosaccharide constituents of CS. In this article, we present a detailed analysis of 46-1 and 46-4.
The structures of the two isomers of CS, chondro-4-sulfate (CS-A) and chondro-6-sulfate (CS-C), and the enzymes involved in CS breakdown are shown in Fig. 1 . CS is first digested to sulfated disaccharides (ADi-4S from CS-A, zADi-6S from CS-C) by chondroitin lyase I and chondroitin lyase II. These two enzymes have been purified and shown to be distinct, although they have similar substrate specificities (10) . The sulfated disaccharides of CS, ADi-4S and ADi-6S, are desulfated by chondro-4-sulfatase and chondro-6-sulfatase, respectively, to form ADi-OS, the unsulfated disaccharide. Finally, ADi-OS is hydrolyzed to monosaccharides by a ,B-glucuronidase. Neither Expression of the genes encoding these CS-degrading enzymes is regulated. That is, elevated levels of these enzymes were seen in cells grown on CS or CS disaccharides but not in cells grown on monosaccharides or unrelated polysaccharides (16) . The enzymes shown in Fig. 1 Fig. 1 were located either in the periplasm or the cytoplasm (17), the outer membrane proteins could be involved in binding and internalization of CS or hyaluronic acid.
The unsulfated mucopolysaccharide, hyaluronic acid is degraded by the same set of enzymes that degrade CS, except that the sulfatases are not needed. Hyaluronic acid, like CS, is a general inducer of the genes in the CS utilization pathway, including genes encoding membrane proteins as well as genes encoding the degradative enzymes (8, 16) . In contrast, the highly sulfated mucopolysaccharide heparin, which differs in both linkage and degree of sulfation from CS, is not digested by CS enzymes and does not act as a general inducer of CS utilization genes (7, 8) . Thus, the heparin utilization system appeared to be completely independent of the CS utilization system. In this article, we present evidence suggesting that the CS and heparin utilization systems are, nonetheless, linked at some level.
MATERIALS AND METHODS
Strains and growth conditions. B. thetaiotaomicron 5482 was obtained from the culture collection of the Virginia Polytechnic Institute Anaerobe Laboratory, Blacksburg. The CS-minus mutants, 46-1 and 46-4, were generated by transposon mutagenesis of B. thetaiotaomicron 5482 by using the Bacteroides transposon Tn4351 (19) . All strains were grown in prereduced Trypticase (BBL Microbiology Systems, Cockeysville, Md.)-yeast extract-glucose broth (6) or in defined medium (18) . In experiments involving twodimensional protein gels, the hemin was replaced by a histidine-hemin solution (9) . Carbohydrate sources added to the defined medium were glucose or glucuronic acid (4 mg/ml), chondroitin sulfate type A (i.e., CS; 3 mg/ml), hyaluronic acid (2 or 3 mg/ml), heparin (3 mg/ml), and N-acetylglucosamine (2 mg/ml). Chondroitin sulfate type A is a mixture of CS-A and CS-C. All carbohydrates used in growth experiments were obtained from Sigma Chemical Co. (St. Louis, Mo.).
Chemical cleavage of ADi-6S. ADi-6S (ICN Immunobiochemicals) was chemically cleaved with mercuric acetate (HgAc) to form unsaturated glucuronic acid and N-acetylgalactosamine 6-sulfate (GalNAc6S) (12) . HgAc Enzyme assays. Assays for chondroitin lyase activity, chondro-4-sulfatase activity, chondro-6-sulfatase activity, and 0-glucuronidase activity have been described previously (4, 5, 17). Chondroitin lyase activity (chondroitin lyase I plus chondroitin lyase II) was determined by measuring the increase in A235 due to the appearance of the double bond formed by the Pi elimination reaction (Fig. 1 ). In the assays for chondro-4-sulfatase, chondro-6-sulfatase, and 3-glucuronidase activities, cell extract (10 to 20 p.g of protein) was incubated with substrate (30 p.g) at 37°C. At 10-to 20-min intervals, portions of the mixture were spotted on paper chromatograms. Development of paper chromatograms and determination of percent substrate converted to product have been described previously (4, 7).
To determine if GalNAc6S could be desulfated by any CS enzymes, GalNAc6S was first prepared by incubating extracts from 46-1 grown on hyaluronic acid with ADi-6S (2 h, 37°C). An equal amount of extract from wild-type B. thetaiotaomicron grown on CS was then added to the reaction mixture and incubated for an additional 2-h period at 37°C before the products on paper chromatograms were analyzed.
Effect of CS on growth of 46-1 on other substrates. Two types of experiments were done to determine if failure of 46-1 to grow on CS was due to accumulation of sulfated disaccharides or GalNAc6S. In one experiment, 46-1 was first inoculated into defined medium containing CS (0.3%) and incubated for 32 h at 37°C. Under these conditions, the OD650 rises to 0.2 to 0.3. In comparison, wild-type bacteria would attain a final OD650 of 0.8 to 1.0. This low level of growth of 46-1 in the CS medium could be due to utilization of CS. However, no induction of CS enzymes was detected in these cells (data not shown). After the 32-h incubation in CS-defined medium, glucuronic acid or glucose was added to a final concentration of 0.4%.
In a second type of experiment, 46-1 was first grown on hyaluronic acid and then inoculated into defined medium containing hyaluronic acid (limiting concentration of 0.1%) plus CS (0.3%), hyaluronic acid only (0.1%), or CS only (0.3%). Growth of 46-1 in the three media was compared. In the medium containing a mixture of hyaluronic acid and CS, the hyaluronic acid was included to maintain expression of CS utilization genes so that accumulation of GalNAc6S could occur. If GalNAc6S or some other toxic intermediate accumulated, growth on the mixture of CS and hyaluronic acid should be slower than growth on hyaluronic acid alone.
Isoelectric focusing. Isoelectric focusing of P-glucuronidase activity in cell extracts from B. thetaiotaomicron (wild type) grown on CS-defined medium was done by using tube b Except for strain 46-4, all strains were grown on hyaluronic acid. Chondroitin sulfatase (CSase) activity is expressed in units per milligram of protein. Chondro-4-sulfatase (4-Sase), chondro-6-sulfatase (6-Sase), and ,B-glucuronidase (1-Gase) activities are expressed as + (ability to convert the substrate to product within 30 min) or -(no conversion of substrate to product detectable after 2 h of incubation).
' 46-4 was grown on glucose.
d Deletion that disrupts csuB (CSaseII) (15) .
e Insertion that disrupts csuC (4-Sase) and has a polar effect on csuB (5). gels (5 mm by 13 cm). Cell extracts were dialyzed against distilled water prior to loading. The composition of the gels and the conditions of electrophoresis have been previously described (2, 14 (2), and the eluted enzyme was incubated with ADi-6S, ADi-4S, or ADi-OS for 2 h at 37°C. Products were analyzed by paper chromatography (5, 17). Two-dimensional protein gels. Two-dimensional gels were done as described in the manual accompanying the twodimensional gel electrophoretic apparatus of Hoefer Scientific Instruments (San Francisco, Calif.) (Sa). The method is based on that described by O'Farrell (13) . Cell extracts were prepared as indicated above except for the following modifications. From a 100-ml culture, the final washed cell pellet was resuspended in 1.0 ml of 50 mM phosphate buffer (pH 7.3). RNase A (2 ,u1 of a 10-mg/ml stock in Tris-EDTA [pH 8 .0]), DNase I (5 p.l of a 10-mg/ml stock in Tris-EDTA [pH 8 .0]), and fresh phenylmethylsulfonyl fluoride (2 p.1 of a 7-mg/ml stock in 100% isopropanol) were added to the suspended cells before the cells were sonicated. After sonication, cell debris was removed by centrifugation as described above. To separate total (inner and outer) membranes from the soluble fraction, the supernatant was ultracentrifuged (70.1 Ti rotor; Beckman Instruments, Inc., Fullerton, Calif.) at 50,000 x g for 2.5 h at 4°C. The resultant supernatant (soluble fraction) was removed and frozen in aliquots (-20°C). The membrane pellet was resuspended, washed once in 10 ml of buffer, and pelleted by ultracentrifugation as described before. The final membrane pellet was resuspended in 100 p.1 of buffer, and the pellet was dispersed by brief sonication. The sample was kept frozen at -20°C. Protein concentrations of both soluble and membrane fractions were determined by the method of Lowry et al. (11) . Membrane (Table 1) . Initially, it appeared that chondro-6-sulfatase activity was also present in these extracts, because the spot corresponding to ADi-6S on the paper chromatograms disappeared when ADi-6S was incubated with the extracts. Normally, incubation of ADi-6S with wild-type extracts results in the production of monosaccharides because of the sequential action of chondro-6-sulfatase and 3-glucuronidase (Fig. 1) . However, incubation of ADi-6S with extracts from 46-1 produced a spot that did not comigrate with monosaccharides or with ADi-OS. The new spot comigrated with ADi-4S, but when sprayed with anisidinephthallic acid, the new spot stained yellow whereas ADi-4S stained a dark brown.
One explanation for the observed reaction was that 46-1 lacked chondro-6-sulfatase activity and the glycosidic linkage in ADi-6S was being hydrolyzed without desulfation to produce GalNAc6S and A3,4-glucuronic acid. Glaser and Conrad (3) showed previously that GalNAc6S comigrated with ADi-4S on paper chromatograms developed with the solvent system employed in our assays. To confirm that the new spot was GalNAc6S, we prepared GalNAc6S from ADi-6S by chemical cleavage with mercuric acetate (12) . This GalNAc6S standard comigrated with the unknown spot and appeared as a yellow spot when sprayed with anisidinephthallic acid.
Breakdown of ADi-6S to GalNAc6S was not seen in extracts from 46-1 grown on glucose. Thus, expression of the enzyme that was hydrolyzing ADi-6S was regulated by CS. A CS-regulated enzyme that might catalyze this type of reaction was ,B-glucuronidase (Fig. 1) . To test this, we used isoelectric focusing gels to separate enzyme activities in extracts from cells grown on CS. Chondro-4-sulfatase and ,B-glucuronidase migrated to different pI values (pls of 4.6 and 4.4, respectively). No chondro-6-sulfatase was detectable in any of the fractions tested. Chondroitin lyase activity focused at the basic end of the gel (10) . The segment of the gel that contained 3-glucuronidase activity, but no chondro-4-sulfatase activity, was the only segment that catalyzed hydrolysis of ADi-6S to GalNAc6S. This activity appeared to be specific for the 6-sulfated disaccharide because eluant from the same segment did not cleave ADi-4S to N-acetylgalactosamine 4-sulfate.
The fact that 3-glucuronidase could hydrolyze ADi-6S raised the possibility that GalNAc6S might actually be an intermediate in CS breakdown. That is, in addition to the desulfation of ADi-6S (by chondro-6-sulfatase), followed by hydrolysis of the resultant ADi-OS disaccharide (by ,B-glucuronidase), ADi-6S might also be cleaved to GalNAc6S (by ,B-glucuronidase), followed by the desulfation of GalNAc6S (Fig. 1) . Clearly, the desulfation of GalNAc6S was not occurring in extracts from 46-1 since GalNAc6S accumulated in the assay mixture. The addition of wild-type extract (see Materials and Methods) did not result in desulfation of GalNAc6S to N-acetylgalactosamine. Thus, GalNAc6S appears not to be further degraded and the action of 1-glucuronidase on ADi-6S is probably a secondary reaction which occurs only if no chondro-6-sulfatase activity is present.
The finding that GaINAc6S was not further degraded raised the question of whether the inability of 46-1 to grow on CS might be due to a toxic effect resulting from accumulation of GalNAc6S during exposure of 46-1 to CS. This appeared not to be the case. First, although 46-1 was incubated in CS-defined medium for 32 h prior to addition of glucose or glucuronic acid, growth on glucose or glucuronic acid occurred as rapidly as when 46-1 was inoculated directly into defined medium containing glucose or glucuronic acid. Thus, if GalNAc6S had accumulated during incubation of 46-1 with CS, it did not kill the cells. In a second type of experiment, in which 46-1 was inoculated into defined medium containing a mixture of hyaluronic acid and CS, growth on the mixture was the same as growth on hyaluronic acid alone. Hence, even when 46-1 was growing on hyaluronic acid and was expressing the proteins needed for CS breakdown, there appeared to be no inhibitory effect of CS.
Other effects of the 46-1 mutation. 46-1 was unable to grow on heparin. This phenotype could not be explained by the loss of chondro-6-sulfatase because previous work had shown that extracts from wild-type B. thetaiotaomicron grown on heparin did not exhibit any detectable chondro-6-sulfatase, chondro-4-sulfatase, or chondroitin lyase activity (7) . In fact, the only CS-associated enzyme detected in extracts from heparin-grown B. thetaiotaomicron was ,Bglucuronidase, which was expressed only at a very low level (7) . Since extracts from 46-1 grown on hyaluronic acid exhibited normal levels of 3-glucuronidase, the heparinminus phenotype was not due to loss of 0-glucuronidase.
Thus, it seemed likely that other proteins beside chondro-6-sulfatase were affected by the mutation in 46-1. We also tested a mutant in which the chondro-4-sulfatase gene had been disrupted (B. thetaiotaomicron fQ815) for the ability to grow on heparin to determine if failure to grow on heparin was a general characteristic of sulfatase-minus mutants. This appeared not to be the case because fQ815 grew as well as the wild type on heparin (Table 1) .
To determine how many proteins were affected by the 46-1 mutation, we compared two-dimensional gel profiles of membrane and soluble fractions from 46-1 grown on glucose or hyaluronic acid with those from the wild type grown on the same substrates. In the wild type, there were 20 soluble proteins and 12 membrane proteins that were expressed at higher levels in cells grown on hyaluronic acid or CS than in cells grown on glucose ( Fig. 2A and B and Fig. 3A and B) .
In the case of 46-1, four soluble hyaluronic acid-induced proteins (with molecular masses of 88, 45, 29, and 27 kDa) were missing ( Fig. 2C and D) . None of the hyaluronic acid-inducible membrane proteins were missing, but a 48-kDa membrane protein was now expressed constitutively ( Fig. 3C and D) . In addition, a 61-kDa membrane protein was seen in extracts of 46-1 grown on hyaluronic acid that did not correspond to any of the proteins detected in extracts of the wild type grown on CS or hyaluronic acid (Fig. 3D,  double arrow) . This 61-kDa membrane protein was induced during growth on hyaluronic acid.
Characteristics of mutant 46-4. Mutant 46-4 was more difficult to characterize than 46-1 because 46-4 did not grow on any of the inducers of csu gene expression (Table 1) . 46-4 was unable to grow on CS, hyaluronic acid, or a mixture of ADi-4S and ADi-6S. 46-4 did, however, grow on heparin and on the monosaccharide constituents of CS. As with the wild type and 46-1, no expression of any of the CS-degrading enzymes was detectable in extracts from 46-4 grown on glucose or N-acetylglucosamine (Table 1) and when 46-4 carrying pVOH5 was grown on glucose. Expression of csuB in the wild type containing pVOH5 (a plasmid with a copy number of at least 5) was 0.1 U/mg protein when cells were grown on glucose and 5.0 U/mg of protein when cells were grown on CS. Thus, even basal-level expression of csuB from pVOH5 was not detected in the 46-4 background.
The growth phenotype of 46-4 allowed us to rule out the possibility that the transposon insertion in 46-4 had interrupted structural genes for the CS-degrading enzymes. 46-4 was unable to grow on hyaluronic acid, whereas a deletion in csuB (chondroitinase II) and an insertion in csuC (chondro-4-sulfatase) were still able to grow on hyaluronic acid (Table  1) . Similarly, loss of chondro-6-sulfatase in 46-1 did not eliminate growth on hyaluronic acid. Thus, the 46-4 insertion did not disrupt csuB, csuC, or csuD. One type of mutation that would be expected to eliminate growth on hyaluronic acid would be disruption of csuE (P-glucuronidase). To determine if csuE was still intact in 46-4, we took advantage of a previous finding that the presence of pVOH5 in the wild type caused a partial derepression of csuE expression (7). That is, when the wild type carrying pVOH5 was grown on glucose, 1-glucuronidase activity was detectable at a level that was nearly 10% of fully induced levels. Normally, in the absence of pVOH5, no ,3-glucuronidase activity was detectable in glucose-grown wild-type cells. The derepression of csuE expression by pVOH5 and other clones carrying the upstream region of the csuCB operon is probably due to titration of a repressor that controls csuE expression (7). To determine if csuE was still intact in 46-4, we tested 46-4 carrying pVOH5 and grown on glucose for I-glucuronidase activity. The rate at which ADi-OS was converted to monosaccharides was the same as that seen in the wild type carrying pVOH5 and grown on glucose. Thus, csuE had not been disrupted in 46-4.
DISCUSSION
The mutation in 46-1 had multiple effects. One effect was the loss of chondro-6-sulfatase activity. The absence of this enzyme allowed us to determine some characteristics of chondro-4-sulfatase and 3-glucuronidase that could not be deduced previously because these enzymes have never been purified. Since extracts of 46-1 exhibited wild-type levels of chondro-4-sulfatase activity but did not desulfate ADi-6S, we can conclude that the chondro-4-sulfatase acts only on ADi-4S and has no activity on ADi-6S. We were also able to demonstrate a previously unsuspected activity of the CSassociated ,B-glucuronidase, i.e., the direct hydrolysis of /Di-6S to produce GalNAc6S and unsaturated glucuronic acid. This reaction was not detectable in wild-type extracts, presumably because the chondro-6-sulfatase desulfates ADi-6S too rapidly to allow appreciable hydrolysis of this substrate by ,B-glucuronidase. Analysis of extracts from 46-1 also allowed us to demonstrate that 1-glucuronidase does not hydrolyze ADi-4S as it does ADi-6S and thus seems to be specific for ADi-6S. It is not clear how much hydrolysis of ADi-6S by ,B-glucuronidase actually occurs when 46-1 is exposed to CS. If it does occur, the accumulation of GalNAc6S appears not to be toxic because exposure of 46-1 to CS did not affect growth on other substrates.
Perhaps the most interesting feature of 46-1 was its inability to grow on heparin. Results of biochemical analyses had indicated that CS and heparin were utilized by different pathways. Also, except for a low-level induction of CSassociated ,B-glucuronidase expression by heparin, the two pathways appeared to be regulated independently of each other (7) . Our If the insertion in 46-1 is in a regulatory locus, the locus only controls expression of a subset of the CS-associated proteins. Two-dimensional gel analysis of wild-type proteins revealed that the CS and hyaluronic acid induce expression of at least 32 proteins, whereas only 6 of these proteins were affected in 46-1.
It is interesting to note that both 46-1, which lacked chondro-6-sulfatase activity, and another mutant, in which the chondro-4-sulfatase gene was disrupted (B. thetaiotaomicron fQ815), were completely unable to grow on CS. Since the CS preparations used to test growth of 46-1 and Q,815 contained a mixture of CS-A and CS-C, some growth should have occurred since the 4-sulfated form could still have been used by 46-1 and the 6-sulfated form could still have been used by fQ815. In contrast, a mutant that was unable to utilize glucuronic acid (PG-4) (18) (18) . At that time, 46-1 appeared to be an exception because 46-1 seemed to be deficient only in utilization of CS. The finding that 46-1 is also unable to utilize heparin shows that 46-1 resembles the other mutants in being affected in more than one polysaccharide utilization pathway.
